XSHE
002899
Market cap438mUSD
Oct 09, Last price
20.34CNY
1D
2.47%
1Q
-0.20%
IPO
-19.98%
Name
IMPULSE (QINGDAO) HEALTH TECH CO.
Chart & performance
P/E
47.73
P/S
2.57
EPS
0.43
Div yield, %
0.38%
Shrs. gr., 5y
4.08%
Rev. gr., 5y
6.21%
Revenues
1.17b
-3.77%
Net income
63m
-42.28%
CFO
126m
-46.78%
Dividend
Jun 12, 20260.083 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Impulse (Qingdao) Health Tech Co., Ltd. engages in the development, manufacture, sale, and brand operation of full range and multi-series fitness equipment. Its products include treadmills, elliptical machines, supine plates, dynamic cycles, fitness cycles, retraining devices, gantry machines, Smith machines and free training devices. The company was founded by Yu Ming Zhu on June 23, 2004 and is headquartered in Qingdao, China.
Headquarters & legal address
即墨区华山二路369号
青岛市, SD 266200
CN
青岛市, SD 266200
CN
Address
NO.369HUASHAN 2ROAD JIMO
Qingdao, SD 266200
CN
Qingdao, SD 266200
CN
Other language
Impulse(Qingdao)Health Tech Co.,Ltd
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||